Objectives: To explore which clinic-level factors influence treatment outcomes in a multisite antiretroviral therapy (ART) programme in South Africa.
Introduction
An unprecedented effort by global organizations, governments and health providers has achieved access to antiretroviral treatment (ART) for over 15.8 million individuals infected with HIV in low-and middleincome countries by June 2015 [1] . In South Africa, an estimated three million people were on ART by June 2015 [2] . The numbers needing treatment is likely to increase due to the recent change in WHO guidelines [3] , as well as new evidence that early ART prevents onward transmission of the virus [4] .
Treatment programmes face the challenge of maximizing retention and maintaining virological suppression for prolonged periods in order to realize the benefits of treatment [5, 6] . The shortage of health workers, exacerbated by inadequate supply, inequitable distribution and accelerated migration [7, 8] , requires an understanding of factors that are most important in achieving good patient outcomes to inform programmatic design.
Most literature has focused on patient-level clinical factors that predict virological outcomes and losses to follow-up [9] [10] [11] [12] . Apart from a few randomized controlled trials looking at a limited number of interventions aimed at improving adherence or retention in patients on ART [13] [14] [15] [16] [17] , information about health systems or clinic-level factors that influence ART outcomes is limited. Review of qualitative studies revealed the following themes organized according to Lavis and colleagues [18] : staffing of the clinic [19] [20] [21] [22] ; the organization of the health system (such as the range of services provided [23] , waiting times [24] , inconsistency regarding payments [24] , provision of social support [25] [26] [27] , follow-up of missed appointments [22] , and availability of privacy [28] ); quality of care (such as quality of counselling [19, [28] [29] [30] [31] and the patient-provider relationship [23, 25, 27, 29, 32] ); and issues specific to ART (medication costs [20] , packaging of medication [33] and cost of additional medical tests [20, 33] ).
Clinic issues may be easier to influence than inherent patient characteristics. The aim of this study was to determine which specific clinic-level factors influence ART treatment outcomes, specifically unsuppressed viral load and loss to follow-up in individuals on antiretroviral therapy.
Methods
Setting and HIV programme description This observational study was conducted in clinics owned by private practitioners or nongovernmental organizations which were part of the Aurum Institute's HIV treatment programme funded through the President's Emergency Plan for AIDS Relief (PEPFAR). The programme provided treatment guidelines, clinical support, training of healthcare workers, site monitoring and a standardized data management system [1] . The clinics, supported by this programme, ranged from urban sophisticated centres to solo general practitioners in rural towns, as described previously [34] .
Clinic and participant selection
From participating clinics, adults (>18 years old) who started on ART from 1 January 2006 to 31 December 2009 were included. Data were included to 31 December 2010. Patients who had a previous history of ART were included as these were primarily women who had received ART for prevention of mother-to-child transmission (PMTCT).
Treatment guidelines
Medical eligibility criteria and treatment guidelines were in line with South African Guidelines for ART initiation in 2006, and these changed in 2010 [35, 36] .
Programmatic collection of patient data
Routine clinical data including demographic and clinical information were collected on standardized forms and entered onto a centrally managed database. Patient data, identified using unique clinic numbers, were integrated with laboratory records, which included CD4 þ cell count and viral load. Patients no longer receiving ART care, for any reason, were reported using deregistration forms. Information on deaths was also ascertained through linkage of the South African identification number to the South African vital statistics registry.
Additional data collection for this study Data collection tools were designed to collect the most important patient and clinic-level factors that might influence patient outcomes as were identified in previous literature reviews of both qualitative and quantitative studies on adherence, retention and virological suppression. Where possible, data collection tools that had already been used in South Africa were sought and adapted for this study [37] [38] [39] . Bundles of information on clinic characteristics were collected using a clinic assessment tool and an interview with a clinic manager or designee. Care was taken to collect information firsthand (staff training from staff rather than managers) to reduce social desirability bias, and, where possible, to measure clinic attributes directly with facility inspection. In addition, all staff members involved in HIV care at each clinic completed a self-administered questionnaire to measure their own education, motivation and working environment.
To control for differences in patient populations between clinics, data on socio-economic factors, not routinely measured in the programme, were collected from a sample of approximately 40 patients per clinic attending for their routine clinic or ART collection visits, as a'proxy' for the overall clinic population. The patient questionnaire also collected information about the patient-provider relationship [37] and patient satisfaction. More detailed questions were added later to the questionnaire; these were only implemented in 19 clinics after obtaining approval for a protocol amendment. The questions added were to measure the following variables: socio-economic status, including an asset score; quality of life (using the EQ-5D questionnaire [40, 41] ); and social capital [42] .
Patient and clinic factors
Patient factors Data measured routinely included age, sex, baseline CD4 þ cell count (closest to ART initiation, up to 91 days before to 14 days after starting ART), baseline viral load (window as for CD4 þ cell count), WHO stage at baseline (within a month of starting ART), previous history of TB, previous ART use and ART regimen.
Clinic factors
Scores were calculated for clinic infrastructure, staff leadership, motivation, burnout, monitoring and evaluation, integration, adherence interventions, and patientprovider relationship. Definitions for each clinic factor, as well as more explanation of each score, are shown in Table 1 . Data from the staff and patient questionnaires from the same clinic were summarized by calculating a mean score at the clinic level. Clinic factors were organized into four groups according to Lavis and colleagues [18] : location of services, health providers, information and quality of services.
Definition of outcomes
The three outcomes were as follows: unsuppressed viral load at 24 months, defined as viral load not less than 400 copies/ml on a single viral load measurement closest to the 24 month point (window 21-27 months), among those with a viral load measurement; time to loss to follow-up: measured from the date of ART initiation to the earliest of death, loss to follow-up, transfer out to a government programme or 31 December 2010. Date of loss to follow-up was determined from deregistration forms or taken as 6 months after the last visit/lab test to the clinic if the patient was no longer active in the clinic. Composite poor outcome at 24 months: viral load at least 400 copies/ml (as above), lost to follow-up or death by 24 months among all patients started on treatment more than 24 months before 31 December 2010. Patients who were in care at 24 months but with no viral load result were excluded.
Data analysis
The analysis to determine which clinic factors were associated with the outcomes was conducted in three stages (Appendix, Figure 1 , http://links.lww.com/QAD/ A864). Patients who died less than 3 months after ART initiation were excluded as deaths during this time were thought to be more closely related to WHO stage, CD4 þ cell count and BMI than adherence to treatment [43] . Stage 1 was based on constructing a model using variables measured at the patient-level. Stage 2 added variables measuring socio-economic status, captured on a sample of patients per clinic and therefore included as a cliniclevel covariate. In stage 3, the association of clinic-level factors on the outcomes was assessed. For simplicity the model building for stages 1 and 2 was based on the outcome of unsuppressed viral load at 12 months.
For all models, random effects regression was used to account for clustering of patient outcomes within a clinic; random-effects logistic and Cox models were used for binary and time to event outcomes, respectively. P values, assessing evidence for clustering, were reported. Each clinic-level variable was categorized either by using the lower and upper quartiles or an alternative categorization, if more established. The clinic-level variables were added to the model and tested for association with the outcome using the likelihood ratio test. Variables that remained associated with the outcome, based on P greater than 0.1, were considered for the final model. As the number of clinics was relatively small, we limited the number of clinic-level variables that were included in the fully adjusted model, by, where possible, only including one variable from each group of clinic-level variables [18] .
A sensitivity analysis was performed with adjustment for the additional patient variables on the subset of clinics which administered the more detailed questionnaire. For the sensitivity analysis, a full multivariable model adjusting for more than one clinic-factor was not developed due to the limited number of sites.
Ethical considerations
The study was approved by the ethics committees of the London School of Hygiene and Tropical Medicine, United Kingdom and the University of the Witwatersrand, South Africa.
Sample size
Sample size calculations were based on formulae for cluster randomized trials [44] for comparison of proportions. We assumed an average of 150 patients per clinic (cluster), type 1 error of 5%, and power of 80 and 90%. Coefficients of variation of 0.06 and 0.46, calculated from data collected routinely from the programme prior to study start, was assumed for unsuppressed viral load and loss to follow-up, respectively. We conducted sample size calculations for a nominal clinic-level exposure assumed to be present in 50% of clinics. For unsuppressed viral load at 24 months, we would require a total of 36 clusters to determine an effect size of at least 1.25 (25% increase in unsuppressed viral load) with 90% power and an effect size of 1.20 with 80% power. For loss to follow-up, a total of 36 clusters, could determine an effect size of at least 1.6 with 80% power and an effect size of 1.70 with 90% power. (6.2%) had not reached 24 months as they were enrolled in 2009 ( Fig. 1 ). Apparently, 5618 (55.9%) patients were still on treatment. Viral load results were available for 4073 (74%), 676 (16.6%) had an unsuppressed viral load.
The composite poor outcome of either unsuppressed viral load, loss to follow-up, or death was determined in 6574 (78%; /8436) of patients at 24 months, 3440(52.3%) had a poor outcome. Fig. 1 . Flow diagram of patient cohort and outcomes. 1 From sites where patient cohort was moved to another programme prior to end of the study or due to transfers to other programmes due to patient request. 2 Patients on treatment for <24 months or from sites that closed prematurely. (Table 4 ). However, clinics with higher levels of staff experience [HR 2.37 of higher vs. lower levels, (CI 1.39 -4.07)] were associated with increased loss to follow-up.
In a sensitivity analysis based on 19 clinics, controlling for measures of social capital and socio-economic status, clinic-level factors were examined individually for associations with unsuppressed viral load and time to loss to follow-up. Lower monitoring and evaluation score was associated with increased odds of unsuppressed viral load [compared with score <19, score 12 For time to loss to follow-up, the lower score for patientprovider relationship was associated with increased loss to follow-up (compared with a score<36: score 36-48 HR 2.41, CI 0.66-8.77; and score >48, HR 13.35, CI 2.10-85.0, P ¼ 0.04). Higher staff turnover (OR 2.38, CI 1.01-5.58) and higher staff burnout (compared with score <7.7 : 7.7-9.9, HR 2.47, CI 0.96-6.37; score>9.9, HR 3.82, CI 1.31-11.16, P trend ¼ 0.01) were also associated with increased loss to follow-up.
Discussion
This observational study, using data from 36 clinics in four provinces in South Africa, found that after adjusting for patient factors, a lower doctor : patient ratio was associated with increased odds of unsuppressed viral load at 24 months in patients on ART, although this association was not found with the loss to follow-up or composite poor outcome. The importance of doctor : patient ratios has previously been shown in the cohort study conducted in 32 public sector clinics in KwaZulu Natal, South Africa, where the risk of default was higher in clinics with a lower doctor : patient ratio and with parttime doctors compared with full time doctors [45] . No other studies have shown this association although many had attempted to measure staff : patient ratios but have not linked these to ART outcomes.
A higher number of interventions to improve adherence was associated with improved retention, lending support to the notion of 'combination adherence promotion' (paraphrasing language used about HIV prevention). The main interventions used were: individual counselling (seven clinics), patient reminders (seven clinics), dedicated staff member to follow-up patients (six clinics), default tracers (five clinics), pre-ART education sessions (four clinics) and treatment supporters (four clinics). Another study, using aggregated data from different clinics [46] in eight resource-limited countries, showed that having a combination of adherence counselling, structured treatment preparation and a community nurse reduced loss to follow-up. As our study was an evaluation under operational conditions we were not able to evaluate specific interventions to promote retention; however, the study suggests that the more the clinics do to promote retention, the better the retention will be.
A higher mean score for patient-provider relationship, measured among a sample of patients at each clinic, was 1104 AIDS 2016, Vol 30 No 7 Table 2 . Outcomes summarized, overall and at the clinic-level (mean, range) and P value for between-clinic variation.
Patients with results
Outcome associated with reduced loss to follow-up in the sensitivity analysis. This is supported by the better outcomes seen in clinics with patients who reported longer time at the clinic. A qualitative interview study of the same programme emphasized the importance of a health provider having more time to form a relationship and discuss issues with the patient (Salome Charalambousunpublished data).
The sensitivity analysis revealed additional clinic factors which on further analysis, we were able to determine, was likely due to the adjustment for additional socioeconomic factors which indicate some residual effect of these factors on the association with outcomes in the main analysis.
Some of the findings, such as staff experience associated with poorer outcomes, were counterintuitive. Staff experience was also associated with male sex and older age of staff members and these may be confounding the association. In our study, longer travel time and higher cost of travel was not associated with poorer outcomes which differs from studies in Malawi, Nigeria and Tanzania [14, 47, 48] . It could be that in South Africa, people have comparatively more disposable income and better road infrastructure making travelling easier and that, coupled with high stigma levels in the community [26, 49] , may result in patients being more prepared to travel longer distances to attend clinics, where they feel care will be confidential.
The biggest strength of this study was the availability of the large number of clinics all using the same treatment guidelines, regimens, data collection tools and a single laboratory for CD4 þ and viral load monitoring. Another strength was the outcome of viral load, arguably the 'gold 1106 AIDS 2016, Vol 30 No 7 standard' for monitoring ART. The use of additional outcomes of loss to follow-up and the use of a composite outcome, combining retention in care and virological outcome, was a further strength. There are few other studies where clinic attributes were measured alongside ART outcomes [50, 51] . Our study also adopted an appropriate statistical analysis, taking into account the clustered design [52] . Many studies looking at clinic factors often did not compare clinics directly or use an analysis taking into account the hierarchical nature of the data [46, 53] . This is however one of the first studies of its kind to try to adjust for patient factors that may explain differences in ART outcomes by clinic.
The use of the routine data led to an analytical limitation as it was not possible to control for individual-level factors such as disclosure of HIV status, use of traditional medicines, religious beliefs and socio-economic status that may determine ART outcomes. To quantify these variables, data were collected from a sample of patients at each clinic and was used in the multivariable model to characterize the clinic populations. However, there may be incomplete control for confounding as data on these factors were not available for every patient included in the main analysis. In addition, the usual problems with routine data were encountered such as missing data; however, we did account for patients with missing viral load in the composite outcome analysis. We also feel that for some clinic factors, such as quality of counselling or quality of clinical care, the measurement may have been superficial and would ideally have required a more detailed assessment.
The clinics included a range of provinces and social contexts, and were made up of small and large practices and so we believe the findings should be relevant in a range of settings, including public facilities. Staff in our study were generally highly motivated and had low burn out. This may differ from public sector facilities: previous studies have shown relatively high motivation [37, 54, 55] , but high levels of burnout among staff at public facilities [37] . We believe that our patients are not too dissimilar to public sector patients as only those who could not afford treatment themselves (earning less than 5000ZAR per month) could be included in the programme, which provided free medication, and the issues examined in this study (of leadership, staffing levels, burn out, staff motivation) would be relevant to most healthcare delivery clinics.
The findings of this study emphasize the importance of staff : patient ratios and the patient-provider relationship.
In the context of scarce human resources, the study findings suggest that antiretroviral delivery is unlikely to become easier for countries to implement. Task-shifting has begun and will need to continue to be implemented to allow for sufficient time for counselling and patient interaction in countries with limited medically trained personnel. This study supports the implementation of 'combination adherence promotion'; however, further research is needed to identify which activities undertaken by clinics are most effective in promoting retention. As the need to sustain more and more people on ART increases, the need to understand how to optimize treatment outcomes and maintain quality of care will become ever more important. 
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